These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25704128)

  • 21. Regulation of medicinal plants for public health--European community monographs on herbal substances.
    Knöss W; Chinou I
    Planta Med; 2012 Aug; 78(12):1311-6. PubMed ID: 22618374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quality control in herbal supplements].
    Oelker L
    Ann Ist Super Sanita; 2005; 41(1):43-8. PubMed ID: 16037649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality and safety of Chinese herbal medicines guided by a systems biology perspective.
    Wang J; van der Heijden R; Spruit S; Hankermeier T; Chan K; van der Greef J; Xu G; Wang M
    J Ethnopharmacol; 2009 Oct; 126(1):31-41. PubMed ID: 19683045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herbal medicine in healthcare--an overview.
    Mosihuzzaman M
    Nat Prod Commun; 2012 Jun; 7(6):807-12. PubMed ID: 22816312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A strategy for evaluating antipyretic efficacy of Chinese herbal medicines based on UV spectra fingerprints.
    Ni LJ; Zhang LG; Hou J; Shi WZ; Guo ML
    J Ethnopharmacol; 2009 Jul; 124(1):79-86. PubMed ID: 19527822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Patented technology status quo and development trend for Chinese herbal medicines].
    Li C; Huang L
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1468-72. PubMed ID: 19771885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey.
    Bush TM; Rayburn KS; Holloway SW; Sanchez-Yamamoto DS; Allen BL; Lam T; So BK; Tran de H; Greyber ER; Kantor S; Roth LW
    Altern Ther Health Med; 2007; 13(2):30-5. PubMed ID: 17405676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some aspects of toxic contaminants in herbal medicines.
    Chan K
    Chemosphere; 2003 Sep; 52(9):1361-71. PubMed ID: 12867165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality requirements for herbal medicinal products in Europe.
    Franz G
    Adv Exp Med Biol; 2004; 546():43-56. PubMed ID: 15584367
    [No Abstract]   [Full Text] [Related]  

  • 31. Quality control of herbal medicines by capillary electrophoresis: potential, requirements and applications.
    Ganzera M
    Electrophoresis; 2008 Sep; 29(17):3489-503. PubMed ID: 18803211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of reporting of randomized controlled trials of herbal medicine interventions.
    Gagnier JJ; DeMelo J; Boon H; Rochon P; Bombardier C
    Am J Med; 2006 Sep; 119(9):800.e1-11. PubMed ID: 16945616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on spectrum-effect relationship of rhizoma Rhei, cortex Magnoliae Officinalis, fructus Aurantii Immaturus and their formula.
    Xie RF; Zhou X; Shi ZN; Li YM; Li ZC
    J Chromatogr Sci; 2013 Jul; 51(6):524-32. PubMed ID: 23118210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herbal medicines in pediatric neuropsychiatry.
    Feucht C; Patel DR
    Pediatr Clin North Am; 2011 Feb; 58(1):33-54, x. PubMed ID: 21281847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-component metabolic classification of commercial feverfew preparations via high-field 1H-NMR spectroscopy and chemometrics.
    Bailey NJ; Sampson J; Hylands PJ; Nicholson JK; Holmes E
    Planta Med; 2002 Aug; 68(8):734-8. PubMed ID: 12221598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From classical taxonomy to genome and metabolome: towards comprehensive quality standards for medicinal herb raw materials and extracts.
    Govindaraghavan S; Hennell JR; Sucher NJ
    Fitoterapia; 2012 Sep; 83(6):979-88. PubMed ID: 22580015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herbal medicines and chronic kidney disease.
    Jha V
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():10-7. PubMed ID: 20586941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactivation of herbal constituents: simple alerts in the complex system.
    Fang ZZ; Zhang YY; Wang XL; Cao YF; Huo H; Yang L
    Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):989-1007. PubMed ID: 21609190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide biological response fingerprinting (BioReF) of the Chinese botanical formulation ISF-1 enables the selection of multiple marker genes as a potential metric for quality control.
    Rong J; Tilton R; Shen J; Ng KM; Liu C; Tam PK; Lau AS; Cheng YC
    J Ethnopharmacol; 2007 Aug; 113(1):35-44. PubMed ID: 17307317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.